HR 1132 RDS 
ing a grant for the establishment or oper-
ation of such program, and any rec-
ommendations for additional requirements 
for protection of this information; 
‘‘(vi) determines the feasibility of im-
plementing technological alternatives to 
centralized data storage, such as peer-to-
peer file sharing or data pointer systems, 
in controlled substance monitoring pro-
grams and the potential for such alter-
natives to enhance the privacy and security 
of individually identifiable data; and 
‘‘(vii) evaluates the penalties that 
States have enacted for the unauthorized 
use and disclosure of information main-
tained in the controlled substance moni-
toring program, and reports on the criteria 
used by the Secretary to determine wheth-
er such penalties qualify as appropriate 
pursuant to this section; and 
‘‘(B) submit a report to the Congress on 
the results of the study. 
‘‘(k) PREFERENCE.—Beginning 3 years after the 
date on which funds are first appropriated to carry out 
this section, the Secretary, in awarding any competitive
HR 1132 RDS 
grant that is related to drug abuse (as determined by the 
Secretary) and for which only States are eligible to apply, 
shall give preference to any State with an application ap-
proved under this section. The Secretary shall have the 
discretion to apply such preference to States with existing 
controlled substance monitoring programs that meet min-
imum requirements under this section or to States that 
put forth a good faith effort to meet those requirements 
(as determined by the Secretary). 
‘‘(l) ADVISORY COUNCIL.—
‘‘(1) ESTABLISHMENT.—A State may establish 
an advisory council to assist in the establishment, 
implementation, or improvement of a controlled sub-
stance monitoring program under this section. 
‘‘(2) LIMITATION.—A State may not use 
amounts received under a grant under this section 
for the operations of an advisory council established 
under paragraph (1). 
‘‘(3) SENSE OF CONGRESS.—It is the sense of 
the Congress that, in establishing an advisory coun-
cil under this subsection, a State should consult with 
appropriate professional boards and other interested 
parties. 
‘‘(m) DEFINITIONS.—For purposes of this section:
HR 1132 RDS 
‘‘(1) The term ‘bona fide patient’ means an in-
dividual who is a patient of the practitioner involved. 
‘‘(2) The term ‘controlled substance’ means a 
drug that is included in schedule II, III, or IV of 
section 202(c) of the Controlled Substance Act. 
‘‘(3) The term ‘dispense’ means to deliver a 
controlled substance to an ultimate user by, or pur-
suant to the lawful order of, a practitioner, irrespec-
tive of whether the dispenser uses the Internet or 
other means to effect such delivery. 
‘‘(4) The term ‘dispenser’ means a physician, 
pharmacist, or other person that dispenses a con-
trolled substance to an ultimate user. 
‘‘(5) The term ‘interoperability’ with respect to 
a State controlled substance monitoring program 
means the ability of the program to electronically 
share reported information, including each of the re-
quired report components described in subsection 
(d), with another State if the information concerns 
either the dispensing of a controlled substance to an 
ultimate user who resides in such other State, or the 
dispensing of a controlled substance prescribed by a 
practitioner whose principal place of business is lo-
cated in such other State.
HR 1132 RDS 
‘‘(6) The term ‘nonidentifiable information’ 
means information that does not identify a practi-
tioner, dispenser, or an ultimate user and with re-
spect to which there is no reasonable basis to believe 
that the information can be used to identify a practi-
tioner, dispenser, or an ultimate user. 
‘‘(7) The term ‘practitioner’ means a physician, 
dentist, veterinarian, scientific investigator, phar-
macy, hospital, or other person licensed, registered, 
or otherwise permitted, by the United States or the 
jurisdiction in which he or she practices or does re-
search, to distribute, dispense, conduct research with 
respect to, administer, or use in teaching or chemical 
analysis, a controlled substance in the course of pro-
fessional practice or research. 
‘‘(8) The term ‘State’ means each of the 50 
States and the District of Columbia. 
‘‘(9) The term ‘ultimate user’ means a person 
who has obtained from a dispenser, and who pos-
sesses, a controlled substance for his or her own use, 
for the use of a member of his or her household, or 
for the use of an animal owned by him or her or by 
a member of his or her household.
HR 1132 RDS 
‘‘(n) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there are authorized to be appro-
priated—
‘‘(1) $15,000,000 for each of fiscal years 2006 
and 2007; and 
‘‘(2) $10,000,000 for each of fiscal years 2008, 
2009, and 2010.’’.
Passed the House of Representatives July 27, 2005. 
Attest: 
JEFF TRANDAHL, 
Clerk.